Skip to main content
Addgene

pGY577
(Plasmid #166663)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 166663 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    PGAE0 Self-Inactivating Vector
  • Backbone size w/o insert (bp) 7208
  • Vector type
    Lentiviral, Cre/Lox

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    LiCre
  • Alt name
    AsLOV2-CreE340AD341A
  • Species
    Synthetic; Avena sativa, Bacteriopage P4
  • Insert Size (bp)
    1497
  • Mutation
    Cre: E340A, D341A
  • Promoter CMV

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site Age1 (unknown if destroyed)
  • 3′ cloning site HindIII (unknown if destroyed)

Resource Information

  • Supplemental Documents
  • A portion of this plasmid was derived from a plasmid made by
    Vector pGAE0 originates from Mangeot et al. Nucleic Acids Research, 2004, Vol. 32, No. 12 e102

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Please note: Plasmid contains a 24bp deletion that removes one of the SV40 NLS tags. This deletion is not known to affect plasmid function.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pGY577 was a gift from Gaël Yvert (Addgene plasmid # 166663 ; http://n2t.net/addgene:166663 ; RRID:Addgene_166663)
  • For your References section:

    A single-chain and fast-responding light-inducible Cre recombinase as a novel optogenetic switch. Duplus-Bottin H, Spichty M, Triqueneaux G, Place C, Mangeot PE, Ohlmann T, Vittoz F, Yvert G. Elife. 2021 Feb 23;10. pii: 61268. doi: 10.7554/eLife.61268. 10.7554/eLife.61268 PubMed 33620312